How many institutions held SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value in Q4 2023?

3 institutional investors reported SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value for Q4 2023. Use the holders table for investor-level position and value details.

China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC)

Q: What does CUSIP G2161P140 represent in this 13F holders report?

CUSIP G2161P140 is the security identifier for SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value used to aggregate holder disclosures.

CUSIP: G2161P140

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common stock, $0.08 par value
Total 13F shares: 9,170
Share change: +9,170
Total reported value: $35,452
Price per share: $3.97
Number of holders: 3
Value change: +$35,452
Number of buys: 3

Security key

G2161P140

Report period

Q4 2023

Institutions

Top holders

SXTC full security history Newer quarter: Q1 2024 China SXT Pharmaceuticals, Inc. SEC filings China SXT Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP G2161P140

Newer quarter: Q1 2024

Recent filing periods:

Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023

Ownership snapshot

Top shareholders of SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.

Lead holder

CITADEL ADVISORS LLC

13D/G signal

—

Evidence rows

Latest as of

30 Sep 2023

13F 3/4/5 Highest disclosed value: $23,535

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
CITADEL ADVISORS LLC	13F Company 13F	— class O/S missing	$23,535 191,339 shares	—	30 Sep 2023
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	— class O/S missing	$12,000 105,039 shares	—	30 Sep 2023
TWO SIGMA SECURITIES, LLC	13F Company 13F	— class O/S missing	$6,146 49,965 shares	—	30 Sep 2023
LEVEL FOUR ADVISORY SERVICES, LLC	13F Company 13F	— class O/S missing	$5,261 42,771 shares	—	30 Sep 2023
HRT FINANCIAL LP	13F Company 13F	— class O/S missing	$5,000 48,507 shares	—	30 Sep 2023
UBS Group AG	13F Company 13F	— class O/S missing	$3,674 29,870 shares	—	30 Sep 2023
Baader Bank Aktiengesellschaft	13F Company 13F	— class O/S missing	$1,415 12,916 shares	—	30 Sep 2023
Qube Research & Technologies Ltd	13F Company 13F	— class O/S missing	$6 50 shares	—	30 Sep 2023
Feng Felix Zhou	3/4/5 Co-CEO and Director, Director 3/4/5	— class O/S missing	— 4 shares	—	04 Jul 2017

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

9,170

Rows loaded

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q4 2024 Across Filers

Q4 2024 holders

Q4 2023 holders

Holder diff

Investor	Q4 2024 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q4 2024 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.